Free Trial
→ Man Who Called Nvidia at $1.10 Says Buy This Now... (From The Oxford Club) (Ad) Free XLO Stock Alerts

Xilio Therapeutics (XLO) SEC Filings & 10K Form

Xilio Therapeutics logo
$0.67 +0.01 (+1.40%)
Closing price 04:00 PM Eastern
Extended Trading
$0.66 0.00 (-0.20%)
As of 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Xilio Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
06/17/2025
4:28 PM		Point72 Asset Management, L.P. (Filed by)
Xilio Therapeutics (Subject)
Form SCHEDULE 13G
06/12/2025
3:55 PM		Frazier Life Sciences Public Fund, L.P. (Filed by)
Xilio Therapeutics (Subject)
Form SCHEDULE 13G
06/12/2025
3:30 PM		Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2025
3:33 PM		Bello Akintunde Olatokumbo (Reporting)
Xilio Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/12/2025
3:34 PM		Bello Akintunde Olatokumbo (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:34 PM		Rossi Christina (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:35 PM		Shannon James Samuel (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:35 PM		Xilio Therapeutics (Issuer)
Xu Yuan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:36 PM		Clancy Paul J (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:36 PM		Curran Daniel J. (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:36 PM		Bonstein Sara (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
3:35 PM		Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025
6:31 PM		GILEAD SCIENCES, INC. (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
6:38 AM		Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025
6:43 AM		Xilio Therapeutics (Filer)
Form DEFA14A
06/03/2025
6:31 AM		Xilio Therapeutics (Filer)
Form 424B5
06/02/2025
5:48 AM		Xilio Therapeutics (Filer)
Form 424B5
06/02/2025
5:08 AM		Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
9:48 AM		Rock Springs Capital Management LP (Filed by)
Xilio Therapeutics (Subject)
Form SCHEDULE 13G/A
05/08/2025
11:15 PM		Xilio Therapeutics (Filer)
Form EFFECT
05/08/2025
3:31 PM		Xilio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
6:35 AM		Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
3:32 PM		Xilio Therapeutics (Filer)
Form S-3/A
04/28/2025
3:30 PM		Xilio Therapeutics (Filer)
Form DEF 14A
04/28/2025
3:32 PM		Xilio Therapeutics (Filer)
Form DEFA14A
04/28/2025
3:33 PM		Xilio Therapeutics (Filer)
Form ARS
04/18/2025
8:30 AM		Xilio Therapeutics (Filer)
Form PRE 14A
04/16/2025
3:30 PM		Frankenfield Christopher James (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
3:30 PM		Russo Rene (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
8:30 AM		Xilio Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/11/2025
7:50 AM		Xilio Therapeutics (Filer)
Form 424B5
03/11/2025
7:54 AM		Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
7:43 AM		Xilio Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2025
7:15 AM		Xilio Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
6:39 AM		Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
6:36 AM		Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
4:09 PM		Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
3:15 PM		GILEAD SCIENCES, INC. (Filed by)
Xilio Therapeutics (Subject)
Form SCHEDULE 13G/A
12/19/2024
3:19 PM		GILEAD SCIENCES, INC. (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
6:45 AM		Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:44 PM		Bain Capital Life Sciences Fund II, L.P. (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G/A
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)

Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).

Click here for the names of our three top stocks to own this year (no purchase necessary).
11/12/2024
3:50 PM		Rock Springs Capital Management LP (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G/A
11/12/2024
9:40 AM		FMR LLC (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G/A
11/07/2024
8:25 AM		Xilio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
8:20 AM		Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
8:36 PM		GKCC, LLC (Filed by)
Xilio Therapeutics (Subject)
Form SC 13G
09/27/2024
8:00 PM		Chudnovsky Yekaterina (Reporting)
GKCC, LLC (Reporting)
Xilio Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2024
6:45 AM		Xilio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:51 AM		Xilio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
7:00 PM		Frankenfield Christopher James (Reporting)
Xilio Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:XLO) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsored
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsored
One stock to replace Nvidia
I'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...
InvestorPlace | Sponsored
Digital Dollar Alert: Protect Your Wealth Before It’s Too Late
134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...
American Alternative | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
[Shocking New Report] U.S. Dollar To Crash?
The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…
Goldco Precious Metals | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored